about
Effects of chlorophenoxy herbicides and their main transformation products on DNA damage and acetylcholinesterase activity.Alzheimer's disease, cholesterol, and statins: the junctions of important metabolic pathways.Alzheimer's disease and antioxidant therapy: how long how far?Alzheimer's disease, enzyme targets and drug discovery struggles: from natural products to drug prototypes.Caffeic acid derivatives, analogs and applications: a patent review (2009-2013).Plant derived and dietary phenolic antioxidants: anticancer properties.Lessons from black pepper: piperine and derivatives thereof.Development of Blood-Brain Barrier Permeable Nitrocatechol-Based Catechol O-Methyltransferase Inhibitors with Reduced Potential for Hepatotoxicity.New insights into the antioxidant activity of hydroxycinnamic and hydroxybenzoic systems: spectroscopic, electrochemistry, and cellular studies.Antioxidant therapy: still in search of the 'magic bullet'.Lipophilic caffeic and ferulic acid derivatives presenting cytotoxicity against human breast cancer cells.Chromone, a privileged scaffold for the development of monoamine oxidase inhibitors.Long Chain Alkyl Esters of Hydroxycinnamic Acids as Promising Anticancer Agents: Selective Induction of Apoptosis in Cancer Cells.Exploring nature profits: development of novel and potent lipophilic antioxidants based on galloyl-cinnamic hybrids.NO and HNO donors, nitrones, and nitroxides: Past, present, and future.Coumarin versus Chromone Monoamine Oxidase B Inhibitors: Quo Vadis?Discovery of New Chemical Entities for Old Targets: Insights on the Lead Optimization of Chromone-Based Monoamine Oxidase B (MAO-B) Inhibitors.Derivatives of caffeic acid, a natural antioxidant, as the basis for the discovery of novel nonpeptidic neurotrophic agents.Discovery of neurotrophic agents based on hydroxycinnamic acid scaffold.Microencapsulation of caffeic acid phenethyl ester and caffeic acid phenethyl amide by inclusion in hydroxypropyl-β-cyclodextrin.Hydroxybenzoic Acid Derivatives as Dual-Target Ligands: Mitochondriotropic Antioxidants and Cholinesterase Inhibitors.Biology-oriented development of novel lipophilic antioxidants with neuroprotective activityDiscovery of two new classes of potent monoamine oxidase-B inhibitors by tricky chemistryExploring cinnamic acid scaffold: development of promising neuroprotective lipophilic antioxidantsModulation of ERK1/2 and Akt Pathways Involved in the Neurotrophic Action of Caffeic Acid Alkyl EstersPharmacodynamic evaluation of novel Catechol-O-methyltransferase inhibitorsCorrection to Discovery of New Chemical Entities for Old Targets: Insights on the Lead Optimization of Chromone-Based Monoamine Oxidase B (MAO-B) InhibitorsCaffeic Acid Alkyl Amide Derivatives Ameliorate Oxidative Stress and Modulate ERK1/2 and AKT Signaling Pathways in a Rat Model of Diabetic RetinopathyBioisosteric OH- to SH-replacement changes the antioxidant profile of ferulic acidBenzoic acid-derived nitrones: A new class of potential acetylcholinesterase inhibitors and neuroprotective agentsRepurposing nitrocatechols: 5-Nitro-α-cyanocarboxamide derivatives of caffeic acid and caffeic acid phenethyl ester effectively inhibit aggregation of tau-derived hexapeptide AcPHF6Insights into the Discovery of Novel Neuroprotective Agents: A Comparative Study between Sulfanylcinnamic Acid Derivatives and Related Phenolic Analogues
P50
Q37700538-34E569A5-577A-4309-8634-520810BB43A0Q38071004-2ADBCA9D-ECE6-451D-83FA-BC45002E1E79Q38081479-B784D421-F36B-4AEA-A5E3-ACD925BACD2EQ38204122-CD49FD2C-3295-4F86-A762-DA1B1D4A25FBQ38256950-85632DF0-BDD2-4EB2-9C0C-7BF03B8E1CAAQ38416096-00927BD7-565D-4896-A1DF-5C285DE6267DQ38631441-1681EA70-5976-4B41-B332-32C6E655A9E0Q38837336-DBE69A26-F0D3-4372-8B6C-BF1A64C0F98AQ38955181-6D538BA0-5AF2-476B-8A56-DC3F249DC89CQ39501996-360EC478-7167-413B-AC15-FCC4FA0BA6E5Q39556292-A704AF6B-A7DB-48D6-8D14-1D5C870D0B76Q42731762-7116A7DA-8B2E-48E9-B081-FC3DC44745ECQ42799010-521E935D-7F9A-46DA-B497-787E3E8F84D8Q43734918-29BD51BF-7FAF-46CE-BE8A-D1A7377B4B0EQ47669705-9DB8032D-3D50-4573-A95E-41C719457BE4Q48328951-414C16FC-3799-471A-A63A-DF172F3C46E7Q48704923-B263DA6D-B887-4558-8CD4-EFBCFB3EA516Q50654555-94BAEB5B-EFD0-453F-8EAB-55BAD5B5A0A2Q51611789-73703B04-CFB4-490F-B900-57527057ED97Q52352503-FC3A6147-7C90-4DDF-AB82-B499A5E13DCAQ55007733-9A4063EF-6D33-4421-A432-2A6CBAA2312CQ56990860-03CEA916-CA41-42B5-8EFD-6AF455BB7029Q56990877-5CECF543-B1A6-46CE-8E46-6E2CE1F4C3EBQ56990886-ECFB4FED-444C-4BE3-8D8B-648F79341541Q60952051-8C9E741F-5721-4E47-BD36-A76E32D268F1Q64782419-805FA8EA-6879-4629-A417-78FDDAABC27CQ88889113-5F8E7B46-9B43-4E7A-A90A-3D813049EB40Q90366554-D2CD2AB5-38EC-420D-9B5C-D012F122A80FQ91052181-5ED019DF-EE81-43CA-8522-13F0013A64C4Q91569104-36B23F72-D0FD-4757-ADBB-2EBD7686C68EQ91643072-53D1D746-91D8-40E1-A1D2-B2D1A8C4A724Q91762250-D94A7C72-8445-4030-A365-30E60248E296
P50
description
researcher ORCID: 0000-0003-0874-5982
@en
wetenschapper
@nl
name
Tiago Silva
@ast
Tiago Silva
@en
Tiago Silva
@es
Tiago Silva
@nl
Tiago Silva
@sl
type
label
Tiago Silva
@ast
Tiago Silva
@en
Tiago Silva
@es
Tiago Silva
@nl
Tiago Silva
@sl
prefLabel
Tiago Silva
@ast
Tiago Silva
@en
Tiago Silva
@es
Tiago Silva
@nl
Tiago Silva
@sl
P106
P1153
25641749600
P21
P31
P496
0000-0003-0874-5982